Induced pluripotent stem (iPS) cells, are a type of pluripotent stem cell derived from adult somatic cells that have been genetically reprogrammed to an embryonic stem (ES) cell-like state through the forced expression of genes and factors important for maintaining the defining properties of ES cells. The global induced pluripotent stem cells market was estimated at USD 2,474 百万 2021 预计将触及美元 4,185 百万 2028, 复合年增长率为 7.8% 从 2022 到 2028 根据Gen Consulting公司的最新报告.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global induced pluripotent stem cells market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the induced pluripotent stem cells industry.

该行业报告提供了全球市场的市场估计和预测, followed by a detailed analysis of the reprogramming method, 功能, 应用, 和地区. The global market for induced pluripotent stem cells can be segmented by reprogramming method: integration-free, 融合的. The integration-free segment is estimated to account for the largest share of the global induced pluripotent stem cells market. Induced pluripotent stem cells market is further segmented by function: cell analysis, cell culture, cell differentiation, cellular reprogramming, molecular and cellular engineering. 根据应用, the induced pluripotent stem cells market is segmented into: academic research, drug development & discovery, toxicity screening, regenerative medicine. 根据地区, the induced pluripotent stem cells market also can be divided into: 亚太地区, 欧洲, 北美, 世界其他地区 (排).

By reprogramming method:
– integration-free
– 融合的

按功能分类:
– cell analysis
– cell culture
– cell differentiation
– cellular reprogramming
– molecular and cellular engineering

按申请:
– academic research
– drug development & discovery, toxicity screening
– regenerative medicine

按地区:
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)

The market research report covers the analysis of key stake holders of the global induced pluripotent stem cells market. Some of the leading players profiled in the report include Allele Biotechnology and Pharmaceuticals, 公司, Axol Bioscience Ltd., Fate Therapeutics, 公司, FUJIFILM Cellular Dynamics, 公司. (FCDI), 龙沙集团公司, 默克公司, Ncardia Services B.V., ReproCELL USA, 公司, 宝生物株式会社, 赛默飞世尔科技公司, ViaCyte, 公司, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the global induced pluripotent stem cells market.
– To classify and forecast the global induced pluripotent stem cells market based on reprogramming method, 功能, 应用, 地区.
– To identify drivers and challenges for the global induced pluripotent stem cells market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global induced pluripotent stem cells market.
– To identify and analyze the profile of leading players operating in the global induced pluripotent stem cells market.

为什么选择这份报告
– Gain a reliable outlook of the global induced pluripotent stem cells market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.